If It’s Okay for Mice, It’s Good Enough for People, Right?
Aug 29th 2022 1:41am EDT
The U.S. Food and Drug Administration appears set to circumvent its own regulatory process in order to authorize Pfizer’s new bivalent COVID-19 vaccine that targets the Omicron BA.4 and BA.5 subvariants — without requiring clinical trials on humans. Powered by WPeMatico
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.